Patent US5092890A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5092890A Expired / Lapsed US ⏱️ 0.0 years remaining

Implant materials for hard tissue

Assignee: BASF SE
•
Filing: 1989-12-29
•
Granted: 1992-03-03
•
Expires: 2009-12-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An implant material for replacing hard tissue containing as essential components A) 30 to 95% by weight of a thermotropically mesomorphic polymer, B) 5 to 70% by weight of an apatite and C) 0 to 60% by weight of a fibrous or particulate filler which differs from B).

Inventors

  • 👤 Heinz Pohlemann
  • 👤 Bernd Hisgen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 03:01
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/40; A61L27/44; A61L27/46; A61L27/50

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 58 words
An implant material for replacing hard tissue, containing as essential components A) 30 to 95% by weight of a thermotropically mesomorphic polymer wherein said polymer comprises at least one aromatic monomer unit, B) 5 to 70% by weight of an apatite and C) 0 to 60% by weight of a fibrous or particulate filler which differs from B).
Claim 2
Dependent Claim 58 words
An implant material for replacing hard tissue, containing as essential components A) 30 to 95% by weight of a thermotropically mesomorphic polymer wherein said polymer comprises at least one aromatic monomer unit, B) 5 to 70% by weight of an apatite and C) 0 to 60% by weight of a fibrous or particulate filler which differs from B).
Claim 3
Dependent Claim 42 words
An implant material as claimed in claim 1, wherein the thermotropically mesomorphic polymer is a polycondensate from the group consisting of polyesters, polyesters amides, polyester imides, polyester carbonates, polyether esters, polyether ester amides, polyester amide imides, polyester carbamides and polyether ester imides.
Claim 4
Dependent Claim 15 words
An implant material as claimed in claim 1 or 2, wherein the apatite is hydroxyapatite.
Claim 5
Dependent Claim 16 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer is completely aromatic.
Claim 6
Dependent Claim 21 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer contains monomer units derived from aromatic dicarboxylic acids.
Claim 7
Dependent Claim 41 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer contains monomer units derived from aromatic diols, aromatic diamines, aromatic diols substituted with an amino or hydroxyl group, or aromatic diamines substituted with an amino or hydroxyl group.
Claim 8
Dependent Claim 25 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer contains monomer units derived from aromatic hydroxycarboxylic acids or aromatic aminocarboxylic acids.
Claim 9
Dependent Claim 25 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer contains monomer units derived from aromatic thiocarboxylic acids, aromatic dithiols or thiophenols.
Claim 10
Dependent Claim 21 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer contains monomer units derived from aliphatic dicarboxylic acids.
Claim 11
Dependent Claim 41 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer contains monomer units derived from aliphatic diols, aliphatic diamines, aliphatic diols substituted with an amino or hydroxyl group or aliphatic diamines substituted with an amino or hydroxyl group.
Claim 12
Dependent Claim 28 words
An implant material as claimed in claim 1, wherein said thermotropically mesomorphic polymer contains monomer units derived from cis-1,4-cyclohexane dicarboxylic acid, trans-1,4-cyclohexane dicarboxylic acid or 1,3-cyclohexane dicarboxylic acid.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-03-03 1995-09-02 1996-03-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-03-03 1999-09-02 2000-03-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-03-03 2003-09-02 2004-03-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag